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Discussion
Dr Jennifer Hirsch-Romano (Ann Arbor, Mich). Thank you
for an excellent presentation and demonstration of very good out-
comes for a challenging population. TV regurgitation certainly is
the bane of existence for surgeons caring for patients with
HLHS, and, as your results demonstrate, this can be a very difficult
lesion to address. You had excellent short-term outcomes but
demonstrated that TR often recurs late for these patients.
We have studied TV repairs quite extensively in our own pa-
tients, and, as a result of those analyses, we have devised a slightly838 The Journal of Thoracic and Cardiovascular Surgone-size-fits-all approach. We have found that in our hands oblit-
erating the posterior leaflet as our form of annuloplasty has been
the most effective, aside from addressing any obvious leaflet struc-
tural abnormalities.
From your study findings, it looks like really AS commissuro-
plasty, plus or minus annuloplasty, has been the most effective
for your patients. Have you noticed since the completion of your
study that there has been a change in approach to these patients
with a more unified surgical plan?
Dr Bautista-Hernandez. These results are very recent. We
conducted this study until January 2014, so as far as I can tell,
we did not change our practice because of this study so far.
We are very aware of your previous publications fromyour insti-
tution on TR, with very good outcomes, too; however, our concern
is that with the bicuspidization of the tricuspid valve, I do not know
how effective thatwill be to address the TR if the jet comes from the
AS commissure, which is what we have seen in our study.
DrHirsch-Romano. Specifically, how do you perform your an-
nuloplasty? Do you perform it with a sizer, and do you use absorb-
able or nonabsorbable suture? This is a 2-pronged question,
because Dr del Nido is also in the audience, what are your thoughts
on bioabsorbable rings in the future for performing annuloplasty
for these patients.
Dr Bautista-Hernandez. That is a very good point. I did not
comment on the technique we used for annuloplasty. In our series,
we have the De Vega annuloplasty, we have partial annuloplasty,
and a few patients received rings. One of them had a resorbable
ring placed and another two had just regular rings. Thus, really,
it has been the surgeon’s preference so far. So that is what I can tell.
Dr Hirsch-Romano.When you perform your annuloplasty, do
you use a sizer at all or is it just based on an ‘‘eyeball’’
measurement?
Dr Bautista-Hernandez. It is a combination of both. We do
measure the TV annulus, but we have not regularly downsized
the valve to a Z-score of 0, for instance, because the Z-scores
were determined from measurements from regular biventricular
hearts and, thus, are really not meant for patients with HLHS.
Dr Hirsch-Romano. In regard to the timing of your TV repair,
we quite often try to address any element of TV regurgitation
before the Fontan operation, partially based on data showing that
the length of cardiopulmonary bypass and crossclamp time at Fon-
tan can affect the long-term outcomes. Can you talk a little bit
about what your decision tree is for the timing of repair.
Dr Bautista-Hernandez. As you are very well aware, we usu-
ally perform the intracardiac tunnel Fontan operation, so those pa-
tients require an aortic crossclamp and opening of the right atrium,
so you have the TV right there. Thus, we usually take advantage of
this approach to repair the TV.
DrHirsch-Romano. So, for patients with mild to moderate TR,
would they tend towait until the Fontan rather than undergoing TV
repair earlier?
Dr Bautista-Hernandez. I mean it depends on every patient. In
the present series, we have some patients who underwent the repair
at stage II, between stage II and III, and even some of them under-
went the repair later on after the Fontan, so it is a tailored approach.
But at the time of the Fontan, because we have the TV there, we try
to fix it if we see more than mild to moderate TR.
Dr Harald L. Lindberg (Oslo, Norway). That was a very nice
presentation. I just wonder, the reason for the TR, have you madeery c September 2014
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timing of volume overload of the heart, if that is correlated to
the occurrence of late TR? I think with your numbers that would
be possible to do.
Dr Bautista-Hernandez. That would be possible to do. But
when we decided to do this study, wewanted to focus on the timing
of stage III, precisely one of the reasons was that. Many reports
have been published stating that perhaps reduction of the volume
overload of the right ventricle at stage II can reduce the amount
of TR. However, the data are controversial, so we tend to repair
whenever we have significant TR at any stage.
Dr Emile Bacha (New York, NY). Victor, great presentation.
Very good results, but disappointing at the same time, because
the RV function was not affected. When you think about what
we try to do, ultimately, we are trying to preserve or even improve
RV function. I am as aggressive as the surgeons in Boston with re-
pairing TVs in patients with HLHS, but it seems to me we are at-
tacking a symptom and not the origin of the problem with HLHS.
The problem might be subendocardial ischemia for all we know,
much like ischemic mitral valve regurgitation. So, can you find
some positive elements for us, that is, improvement in survival,
for example, or better freedom from transplantation, in the patients
who underwent TV repair? Are we actually doing something good
for these patients when we repair the TV?
Dr Bautista-Hernandez. That is an excellent point, but we did
not compare patients who did not undergo TV repair in the present
study, so I cannot really answer your question.
Dr Bacha. But you know that group of patients very well. Do
you have an impression, at least, compared with the non-tricuspid
valvuloplasty patients?
Dr Bautista-Hernandez. Thosewho did not undergo TV repair
and had significant TR, you mean?
Dr Bacha. Yes, or even those who did not have much TR. I
mean, do they have the same survival? Do we, perhaps, by repair-
ing the TVs, not affect the RV function, but their survival then
equals those who never had TR? Do we achieve that by repairing
their TVs?
Dr Bautista-Hernandez. My impression is that survival im-
proves. We also had a presentation at the American Heart Associ-
ation meeting in 2006, with preliminary data from Boston. We
were able to compare 2 groups of patients with HLHS and signif-
icant TR, those who had undergone tricuspid valvuloplasty and
those who had not. We found that those patients who had under-
gone TV repair did better than those who had not but had signifi-
cant TR; thus, tricuspid valvuloplasty improved the outcomes in
that challenging population.
Dr TaraKaramlou (San Francisco, Calif). Two questions. One
of my questions is, again, regarding the timing. Could you, based
on your data, try to differentiate whether particular mechanisms of
TR would improve solely by unloading at the Glenn procedure or
were these all structural issues that required valvuloplasty or other
reparative techniques? That is the first question.
Dr Bautista-Hernandez.We did not have many patients at the
time of stage II, so we cannot really answer that question. We do
not have enough patients to answer that question.
Dr Karamlou. It might be interesting to try to look at that as
you gather more patients.
Dr Bautista-Hernandez. Sure.The Journal of Thoracic and CaDrKaramlou. Then, the second question is, you again were de-
laying a number of these repairs until the Fontan. Do you think you
would have seen an incremental benefit in RV function had you
intervened on the TV earlier, say at the Glenn?
Dr Bautista-Hernandez. With respect to the RV function
before the first repair, which was undertaken for most patients at
stage III, we did not have patients with severe RV dysfunction.
So, I do not think that just by waiting until stage III that a signif-
icant worsening in RV function occurs. However, in our series, we
performed tricuspid valvuloplasty whenever necessary through
staged palliation.
Dr Christopher A. Caldarone (Toronto, Ontario, Canada).
That was a very nice presentation. If you do not mind, could you
just tell us a little bit more about the relationship between the ante-
rior leaflet prolapse and the anterior PM repositioning. You identi-
fied anterior leaflet prolapse as an important indicator of a bad
actor, and I think that is a very important observation. You also
stated that anterior PM repositioning was effective in your
analysis.
First, could you actually conclude that anterior PM reposition-
ing was statistically important?
Second, what was the relationship of anterior PM repositioning
with regard to the subset of patients with anterior leaflet prolapse?
Dr Bautista-Hernandez. That is a very good question. This se-
ries goes from 2000 to 2012; thus, PM repositioning is a technique
we have recently introduced into our clinical armamentarium.
Therefore, it was not being performed at the beginning of our
study. At that time, we were mainly using AS commissuroplasty.
Moreover, we had just a few patients with PM repositioning in
our series; thus, we cannot ensure that it is an effective technique.
In addition, we do not have long-term follow-up data for those pa-
tients, so we must be cautious about sending out the message that
PM repositioning is an outstanding technique.
Dr Caldarone.Well, it might very well turn out to be. Among
all the techniques you have described, anterior PM repositioning is
the only technique that manages the subvalvular support rather
than just the level of the annulus and the leaflet. So I think it prob-
ably will be very important. But I just wanted to see whether you
could actually state that you have proved the point, and it sounds
like it is premature to do so.
Dr Bautista-Hernandez. It is premature. But our last conclu-
sion was exactly that. Perhaps with this approach we can treat,
not only the annulus, but also the subvalvular apparatus and, there-
fore, approach patients with a tailored surgical repair. I mean that
you study the patient preoperatively and decide which technique
will be a better fit.
Dr Carl L. Backer (Chicago, Ill). When you perform a valvu-
loplasty, are you closing the commissure between the anterior and
septal leaflets with interrupted sutures?
Dr Bautista-Hernandez. The commissuroplasty you mean?
Dr Backer. Yes.
Dr Bautista-Hernandez. Yes.
Dr Backer. Let me poll the audience. I have always used the
posterior leaflet obliteration technique described by the Michigan
group. Let us take a vote and see how many surgeons are primarily
using that posterior leaflet obliteration technique.
(Show of hands.)
I see about 10 hands.rdiovascular Surgery c Volume 148, Number 3 839
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Boston strategy?
(Show of hands.)
That looks like about 50 to 60 hands.
How many people are routinely placing an annuloplasty, some
sort of an annuloplasty, when they operate on these patients?
(Show of hands.)
I see about 20 hands.
And, how many surgeons rarely, if ever, use annuloplasty?840 The Journal of Thoracic and Cardiovascular Surg(Show of hands.)
It looks like about 40 hands. It appears we do not have
this problem completely figured out. We need to keep work-
ing on it.
Dr Hirsch-Romano. And how many people are using rings?
(Show of hands.)
Dr Hirsch-Romano. So 1.
So Dr Del Nido, you have your work cut out for you.
Dr Backer. Perhaps next year’s presidential address.ery c September 2014
